These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 36620877

  • 21. miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells.
    Li J, Wang Y, Luo J, Fu Z, Ying J, Yu Y, Yu W.
    FEBS Lett; 2012 Oct 19; 586(20):3761-5. PubMed ID: 23010597
    [Abstract] [Full Text] [Related]

  • 22. B7-H4 expression promotes non-small cell lung cancer progression via AMPK/mTOR signaling.
    Li M, Che N, Feng Y, Liu X, Piao L, Xuan Y, Jin Y.
    Exp Mol Pathol; 2022 Apr 19; 125():104755. PubMed ID: 35278461
    [Abstract] [Full Text] [Related]

  • 23. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
    Yin C, Lin X, Wang Y, Liu X, Xiao Y, Liu J, Snijders AM, Wei G, Mao JH, Zhang P.
    Cell Oncol (Dordr); 2020 Jun 19; 43(3):395-407. PubMed ID: 32006253
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
    Yang Y, Sun Y, Wu Y, Tang D, Ding X, Xu W, Su B, Gao W.
    Mol Carcinog; 2018 Jul 19; 57(7):842-853. PubMed ID: 29566281
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway.
    Mi K, Zeng L, Chen Y, Ning J, Zhang S, Zhao P, Yang S.
    Cell Signal; 2024 Jan 19; 113():110962. PubMed ID: 37931691
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C, Shan Z, Hong J, Yang L.
    Int J Oncol; 2017 Jul 19; 51(1):235-244. PubMed ID: 28534966
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation.
    Yang K, Jiang L, Hu Y, Yu J, Chen H, Yao Y, Zhu X.
    J Exp Clin Cancer Res; 2015 May 03; 34(1):40. PubMed ID: 25935853
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. FoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis.
    Xu N, Jia D, Chen W, Wang H, Liu F, Ge H, Zhu X, Song Y, Zhang X, Zhang D, Ge D, Bai C.
    PLoS One; 2013 May 03; 8(3):e59412. PubMed ID: 23536876
    [Abstract] [Full Text] [Related]

  • 40. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
    Han W, Ren X, Yang Y, Li H, Zhao L, Lin Z.
    Thorac Cancer; 2020 Jun 03; 11(6):1679-1688. PubMed ID: 32364673
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.